Azactam Injection, Powder, For Solution
Product Images NDC 0003-2560

5 FDA label images from E.r. Squibb & Sons, L.l.c. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Azactam (NDC 0003-2560). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by E.r. Squibb & Sons, L.l.c., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sructural Formula Aztreonam.jpg (Chem Structure)

Sructural Formula Aztreonam.jpg (Chem Structure)
Chemical structure diagram of aztreonam, showing its molecular components and arrangement.*
FDA Label Image

Serum Concentrations Of Aztreonam In Healthy Subjects Following Completion Of Single Intramuscular Injections Of 500 mg And 1 G Doses (Serum Concentration)

Serum Concentrations Of Aztreonam In Healthy Subjects Following Completion Of Single Intramuscular Injections Of 500 mg And 1 G Doses (Serum Concentration)
A pharmacokinetic curve illustrating Aztreonam serum concentration (mcg/mL) over time (hours) for different dosages and routes. The curves compare 2 g intravenous (IV), 1 g intravenous (IV), 1 g intramuscular (IM), and 500 mg intramuscular (IM) administrations, showing serum concentration decline over 8 hours.*
FDA Label Image

Clcr-equation (Clcr Equation)

Clcr-equation (Clcr Equation)
An equation diagram illustrating the formula to calculate creatinine clearance (ClCr) in males and females. For males, ClCr equals weight in kilograms multiplied by (140 minus age), divided by 72 times serum creatinine in mg/dL. For females, the value is 0.85 times the male calculation.*
FDA Label Image

Vial Label 1g.jpg (Vial Label 1g)

Vial Label 1g.jpg (Vial Label 1g)
Label for AZACTAM 1 gram injection powder for solution, containing aztreonam. The label indicates use for intravenous or intramuscular administration, single-dose vial, manufactured by Bristol Myers Squibb. Storage instructions recommend keeping the powder at 20°C to 25°C and avoiding excessive heat. The label includes a barcode and space for lot and expiration dates.*
FDA Label Image

Vial-label-2g.jpg (Vial Label 2g)

Vial-label-2g.jpg (Vial Label 2g)
Label for AZACTAM 2 grams (aztreonam for injection, USP) powder for solution injection. It is for intravenous or intramuscular use, provided in a single-dose vial with instructions to discard unused portions. The label includes prescribing information, storage instructions, and is manufactured by Bristol Myers Squibb Company.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.